From: Evaluating antimicrobial prescribing in a Tertiary Healthcare Institution in Nigeria
Age (years) | Oral n (%) | Parenteral n (%) | Other forms n (%) | Total |
---|---|---|---|---|
AD | 54 (100) | 0 (0.00) | 0 (0.00) | 54 |
16–20 | 10 (90.91) | 1 (9.09) | 0 (0.00) | 11 |
21–25 | 23 (95.83) | 0 (0.00) | 1 (4.17) | 24 |
26–30 | 25 (92.59) | 1 (3.70) | 1 (3.70) | 27 |
31–35 | 38 (97.44) | 1 (2.56) | 0 (0.00) | 39 |
36–40 | 52 (94.55) | 2 (3.64) | 1 (1.82) | 55 |
41–45 | 54 (98.18) | 0 (0.00) | 2 (1.82) | 55 |
46–50 | 61 (98.39) | 1 (1.61) | 0 (0.00) | 62 |
51–55 | 40 (93.02) | 2 (4.65) | 1 (2.33) | 43 |
56–60 | 17 (100) | 0 (0.00) | 0 (0.00) | 17 |
61–65 | 20 (100) | 0 (0.00) | 0 (0.00) | 20 |
66–70 | 10 (100) | 0 (0.00) | 0 (0.00) | 10 |
71–75 | 12 (100) | 0 (0.00) | 0 (0.00) | 12 |
76–80 | 1 (100) | 0 (0.00) | 0 (0.00) | 1 |
81–85 | 1 (100) | 0 (0.00) | 0 (0.00) | 1 |
86–90 | 2 (100) | 0 (0.00) | 0 (0.00) | 2 |
Total | 420 (97.00) | 8 (1.85) | 5 (1.15) | 433 |